Patents by Inventor Roger E. Newton

Roger E. Newton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5256698
    Abstract: The method and composition for treating psychotic disorders with psychoactive drugs which bind at the sigma binding site and act as antagonists to inhibiting psychotic action. The preferred compounds are N-cyclohexyl-N-ethyl benzylamine, N-cyclohexyl-N-ethyl 2-phenylethylamine, and bromhexine.
    Type: Grant
    Filed: July 24, 1990
    Date of Patent: October 26, 1993
    Assignee: University of Iowa Research Foundation
    Inventors: Ronald D. Schoenwald, Charles F. Barfknecht, Roger E. Newton
  • Patent number: 5226568
    Abstract: A plastic squeeze container for dispensing an appropriate solution is disclosed. The top of the container includes a cone-shaped portion which serves as a stem or core for a valve assembly which includes an elastomeric seal which overlies and resiliently grips and circumferentially seals around the stem. The seal also covers an aperture in the container top adjacent the stem. A small central aperture in the seal where it overlies the closing of the stem, enables dispensing contents from the container when the container is squeezed, as the resulting internal pressure causes the seal to balloon slightly away from the stem and permit passage of the solution from the container through the container aperture and through the seal central aperture. When the external pressure is removed, the seal resiliently retracts against the stem and closes the container.
    Type: Grant
    Filed: January 13, 1992
    Date of Patent: July 13, 1993
    Assignee: Blairex Laboratories Inc.
    Inventors: Roger E. Newton, Melvin D. Walters
  • Patent number: 4782060
    Abstract: Gepirone and its pharmaceutically acceptable salts are useful in alleviation of panic disorders which can take the form of clinical syndromes comprising, for example, panic attacks, agoraphobia and phobic anxiety.
    Type: Grant
    Filed: July 29, 1987
    Date of Patent: November 1, 1988
    Assignee: Bristol-Myers Company
    Inventors: Neil Kurtz, Roger E. Newton, Davis L. Temple, Jr.
  • Patent number: 4634703
    Abstract: Buspirone and its pharmaceutically acceptable salts are useful in alleviation of panic disorders which can take the form of clinical syndromes comprising, for example, panic attacks, agoraphobia and phobic anxiety.
    Type: Grant
    Filed: October 25, 1985
    Date of Patent: January 6, 1987
    Assignee: Bristol-Myers Company
    Inventors: Neil M. Kurtz, Roger E. Newton, Davis L. Temple, Jr.
  • Patent number: 4182763
    Abstract: Buspirone hydrochloride is an effective anti-anxiety agent for the palliative treatment of neurotic patients in which symptoms of anxiety are predominant at doses which are without observable effect in either normal individuals or psychotic patients.
    Type: Grant
    Filed: May 22, 1978
    Date of Patent: January 8, 1980
    Assignee: Mead Johnson & Company
    Inventors: George P. Casten, Gordon R. McKinney, Roger E. Newton, E. Crosby Tompkins, John H. Weikel, Jr.